secwatch.observer — SEC 8-K summary
======================================

Issuer:     DENTSPLY SIRONA Inc. (XRAY)
CIK:        0000818479
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0000818479-25-000152
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dentsply Sirona Q2 net sales $936M (-4.9%); adjusted EPS $0.52 (+6.6%); appoints new CEO Dan Scavilla
--------------------------------------------------------------------------------

- Net sales $936M, down 4.9% (down 6.7% constant currency); GAAP net loss ($45M) or ($0.22) per share.
- Adjusted EPS $0.52 vs $0.49; adjusted EBITDA margin 21.1% vs 17.5% (14.6% growth).
- Executed $550M debt offering; reaffirmed FY25 outlook.
- Dan Scavilla appointed CEO effective Aug 1, 2025; Matt Garth as CFO effective May 30, 2025.
- Byte sales had a 3.2% negative impact on constant currency sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818479/000081847925000152/0000818479-25-000152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818479/000081847925000152/xray-20250807.htm
  HTML page:      https://secwatch.observer/filing/0000818479-25-000152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer